• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2004 Fiscal Year Final Research Report Summary

Study of a novel signal transduction pathway mediated by fibroblast growth factor receptor(FGFR)

Research Project

Project/Area Number 15590251
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General medical chemistry
Research InstitutionWakayama Medical University

Principal Investigator

YOKOTE Hideyuki  Wakayama Medical University, Molecular medicine, Assistant professor, 付置研究所, 助手 (60316122)

Co-Investigator(Kenkyū-buntansha) SAKAGUCHI Kazushige  Wakayama Medical University, Molecular medicine, professor, 付置研究所, 教授 (60178548)
JING Xuefeng  Wakayama Medical University, Molecular medicine, Assistant professor, 付置研究所, 助手 (70316123)
Project Period (FY) 2003 – 2004
KeywordsFGFR / Eph / Neural stem cell
Research Abstract

We hypothesized that neural stem cell growth, differentiation and chemotaxsis are regulated by molecular interaction between FGFR and Eph. Our study is focused on elucidation of a novel signaling mechamism through FGFR-EphA4 complex. Our summary of findings are described bellow.
(1)Physiological significance of FGFR-EphA4 interaction
Ephrin stimulation of differentiated P19 cellls expressing both FGFR and EphA4 promoted FGFR-EphA4 complex formation and then activated EphA4 trans-phosphorylated FGFR. Futhermore, colocalization of FGFR and EphA4 on P19 cells and neural stem cells was shown by immunocytochemical study, indicating that FGFR interacts with EphA4 phisiologically.
(2)FGFR-EphA4 complex formation increased FRS2-Ras-MAPK signaling through FGFR
FRS2 is well known as a down strem molecule activated by FGFR. We found a complex formation of FRS2-FGFR-EphA4 in mouse neural stem cells and this interaction increasesd Ras-MAPK signaling.
Our results suggested that FGFR-EphA4 interaction was important for neurogenesis and regeneration.

URL: 

Published: 2006-07-11  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi